-
1
-
-
77949482691
-
Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs
-
2763315, 19851470
-
Kukar M, Petryna O, Efthimiou P. Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs. Biologics 2009, 3:443-457. 2763315, 19851470.
-
(2009)
Biologics
, vol.3
, pp. 443-457
-
-
Kukar, M.1
Petryna, O.2
Efthimiou, P.3
-
2
-
-
77950833122
-
Is there an increased risk of lymphoma and malignancies under anti-TNF therapy in IBD?
-
10.2174/138945010790309867, 20210767
-
Lakatos PL, Miheller P. Is there an increased risk of lymphoma and malignancies under anti-TNF therapy in IBD?. Curr Drug Targets 2010, 11:179-86. 10.2174/138945010790309867, 20210767.
-
(2010)
Curr Drug Targets
, vol.11
, pp. 179-186
-
-
Lakatos, P.L.1
Miheller, P.2
-
3
-
-
60649108789
-
Gene therapy of the rheumatic diseases: 1998 to 2008
-
10.1186/ar2563, 2688220, 19232068
-
Evans CH, Ghivizzani SC, Robbins PD. Gene therapy of the rheumatic diseases: 1998 to 2008. Arthritis Res Ther 2009, 11:209. 10.1186/ar2563, 2688220, 19232068.
-
(2009)
Arthritis Res Ther
, vol.11
, pp. 209
-
-
Evans, C.H.1
Ghivizzani, S.C.2
Robbins, P.D.3
-
4
-
-
77950657693
-
Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study
-
10.3899/jrheum.090817, 20032102
-
Mease PJ, Wei N, Fudman EJ, Kivitz AJ, Schechtman J, Trapp RG, Hobbs KF, Greenwald M, Hou A, Bookbinder SA, Graham GE, Wiesenhutter CW, Willis L, Ruderman EM, Forstot JZ, Maricic MJ, Dao KH, Pritchard CH, Fiske DN, Burch FX, Prupas HM, Anklesaria P, Heald AE. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study. J Rheumatol 2010, 37:692-703. 10.3899/jrheum.090817, 20032102.
-
(2010)
J Rheumatol
, vol.37
, pp. 692-703
-
-
Mease, P.J.1
Wei, N.2
Fudman, E.J.3
Kivitz, A.J.4
Schechtman, J.5
Trapp, R.G.6
Hobbs, K.F.7
Greenwald, M.8
Hou, A.9
Bookbinder, S.A.10
Graham, G.E.11
Wiesenhutter, C.W.12
Willis, L.13
Ruderman, E.M.14
Forstot, J.Z.15
Maricic, M.J.16
Dao, K.H.17
Pritchard, C.H.18
Fiske, D.N.19
Burch, F.X.20
Prupas, H.M.21
Anklesaria, P.22
Heald, A.E.23
more..
-
5
-
-
0033517113
-
Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis
-
10.1084/jem.190.3.385, 2195592, 10430627
-
Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999, 190:385-398. 10.1084/jem.190.3.385, 2195592, 10430627.
-
(1999)
J Exp Med
, vol.190
, pp. 385-398
-
-
Rabinovich, G.A.1
Daly, G.2
Dreja, H.3
Tailor, H.4
Riera, C.M.5
Hirabayashi, J.6
Chernajovsky, Y.7
-
6
-
-
0036936788
-
Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product
-
10.1006/mthe.2002.0808, 12498769
-
Chan JM, Villarreal G, Jin WW, Stepan T, Burstein H, Wahl SM. Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product. Mol Ther 2002, 6:727-736. 10.1006/mthe.2002.0808, 12498769.
-
(2002)
Mol Ther
, vol.6
, pp. 727-736
-
-
Chan, J.M.1
Villarreal, G.2
Jin, W.W.3
Stepan, T.4
Burstein, H.5
Wahl, S.M.6
-
7
-
-
77649121784
-
Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis
-
10.1002/art.27302, 20187132
-
Khoury M, Courties G, Fabre S, Bouffi C, Seemayer CA, Vervoordeldonk MJ, Tak PP, Jorgensen C, Apparailly F. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis. Arthritis Rheum 2010, 62:765-770. 10.1002/art.27302, 20187132.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 765-770
-
-
Khoury, M.1
Courties, G.2
Fabre, S.3
Bouffi, C.4
Seemayer, C.A.5
Vervoordeldonk, M.J.6
Tak, P.P.7
Jorgensen, C.8
Apparailly, F.9
-
8
-
-
38049063424
-
An altered peptide ligand of type II collagen suppresses autoimmune arthritis
-
Myers LK, Tang B, Rosioniec EF, Stuart JM, Kang AH. An altered peptide ligand of type II collagen suppresses autoimmune arthritis. Crit Rev Immunol 2007, 27:345-356.
-
(2007)
Crit Rev Immunol
, vol.27
, pp. 345-356
-
-
Myers, L.K.1
Tang, B.2
Rosioniec, E.F.3
Stuart, J.M.4
Kang, A.H.5
-
9
-
-
0018602259
-
Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens
-
10.1002/art.1780220406, 426881
-
Stuart JM, Cremer MA, Dixit SN, Kang AH, Townes AS. Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum 1979, 22:347-352. 10.1002/art.1780220406, 426881.
-
(1979)
Arthritis Rheum
, vol.22
, pp. 347-352
-
-
Stuart, J.M.1
Cremer, M.A.2
Dixit, S.N.3
Kang, A.H.4
Townes, A.S.5
-
10
-
-
77950821981
-
Collagen-induced arthritis
-
New York, NY: Wiley & Sons, Coico R, Shevach E
-
Rosloniec EF, Kang AH, Myers LK, Cremer MA. Collagen-induced arthritis. Current Protocols in Immunology 2010, 15.5.1-15.5.25. New York, NY: Wiley & Sons, Coico R, Shevach E.
-
(2010)
Current Protocols in Immunology
-
-
Rosloniec, E.F.1
Kang, A.H.2
Myers, L.K.3
Cremer, M.A.4
-
12
-
-
0031816463
-
Efficient identification of recombinant adenoviruses by direct plaque screening
-
10.1089/dna.1998.17.643, 9703023
-
Lu Y, Zhang Y, Steiner MS. Efficient identification of recombinant adenoviruses by direct plaque screening. DNA Cell Biol 1998, 17:643-645. 10.1089/dna.1998.17.643, 9703023.
-
(1998)
DNA Cell Biol
, vol.17
, pp. 643-645
-
-
Lu, Y.1
Zhang, Y.2
Steiner, M.S.3
-
13
-
-
0031973115
-
Expression and characterization of recombinant human type II collagens with low and high contents of hydroxylysine and its glycosylated forms
-
10.1016/S0945-053X(98)90004-X, 9503366
-
Nokelainen M, Helaakoski T, Myllyharju J, Notbohm H, Pihlajaniemi T, Fietzek PP, Kivirikko KI. Expression and characterization of recombinant human type II collagens with low and high contents of hydroxylysine and its glycosylated forms. Matrix Biol 1998, 16:329-338. 10.1016/S0945-053X(98)90004-X, 9503366.
-
(1998)
Matrix Biol
, vol.16
, pp. 329-338
-
-
Nokelainen, M.1
Helaakoski, T.2
Myllyharju, J.3
Notbohm, H.4
Pihlajaniemi, T.5
Fietzek, P.P.6
Kivirikko, K.I.7
-
14
-
-
0032194109
-
Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis
-
Myers LK, Tang B, Rosloniec EF, Stuart JM, Chiang TM, Kang AH. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis. J Immunol 1998, 161:3589-3595.
-
(1998)
J Immunol
, vol.161
, pp. 3589-3595
-
-
Myers, L.K.1
Tang, B.2
Rosloniec, E.F.3
Stuart, J.M.4
Chiang, T.M.5
Kang, A.H.6
-
15
-
-
15444369239
-
Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints
-
Latham KA, Whittington KB, Zhou R, Qian Z, Rosloniec EF. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints. J Immunol 2005, 174:3978-3985.
-
(2005)
J Immunol
, vol.174
, pp. 3978-3985
-
-
Latham, K.A.1
Whittington, K.B.2
Zhou, R.3
Qian, Z.4
Rosloniec, E.F.5
-
16
-
-
0036177816
-
The role of IL-4 in regulation of murine collagen-induced arthritis
-
10.1006/clim.2001.5162, 11846461
-
Myers LK, Tang B, Stuart JM, Kang AH. The role of IL-4 in regulation of murine collagen-induced arthritis. Clin Immunol 2002, 102:185-191. 10.1006/clim.2001.5162, 11846461.
-
(2002)
Clin Immunol
, vol.102
, pp. 185-191
-
-
Myers, L.K.1
Tang, B.2
Stuart, J.M.3
Kang, A.H.4
-
17
-
-
77649236875
-
Development and validation of gene therapies in autoimmune diseases: Epidemiology to animal models
-
10.1016/j.autrev.2009.12.009, 20035901
-
Leung PS, Shu SA, Kenny TP, Wu PY, Tao MH. Development and validation of gene therapies in autoimmune diseases: Epidemiology to animal models. Autoimmun Rev 2010, 9:A400-405. 10.1016/j.autrev.2009.12.009, 20035901.
-
(2010)
Autoimmun Rev
, vol.9
-
-
Leung, P.S.1
Shu, S.A.2
Kenny, T.P.3
Wu, P.Y.4
Tao, M.H.5
-
18
-
-
19144364120
-
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
-
10.1089/hum.1996.7.10-1261, 8793551
-
Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R, Bahnson AB, Barranger JA, Elders EM, Gay S, Tomaino MM, Wasko MC, Watkins SC, Whiteside TL, Glorioso JC, Lotze MT, Wright TM. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996, 7:1261-1280. 10.1089/hum.1996.7.10-1261, 8793551.
-
(1996)
Hum Gene Ther
, vol.7
, pp. 1261-1280
-
-
Evans, C.H.1
Robbins, P.D.2
Ghivizzani, S.C.3
Herndon, J.H.4
Kang, R.5
Bahnson, A.B.6
Barranger, J.A.7
Elders, E.M.8
Gay, S.9
Tomaino, M.M.10
Wasko, M.C.11
Watkins, S.C.12
Whiteside, T.L.13
Glorioso, J.C.14
Lotze, M.T.15
Wright, T.M.16
-
19
-
-
58849159153
-
Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis
-
10.1089/hum.2008.075, 2855248, 18986219
-
Wehling P, Reinecke J, Baltzer AA, Granrath M, Schulitz KP, Schultz C, Krauspe R, Whiteside T, Elder E, Ghivizzani SC, Robbins PD, Evans CH. Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis. Hum Gene Ther 2009, 20:97-101. 10.1089/hum.2008.075, 2855248, 18986219.
-
(2009)
Hum Gene Ther
, vol.20
, pp. 97-101
-
-
Wehling, P.1
Reinecke, J.2
Baltzer, A.A.3
Granrath, M.4
Schulitz, K.P.5
Schultz, C.6
Krauspe, R.7
Whiteside, T.8
Elder, E.9
Ghivizzani, S.C.10
Robbins, P.D.11
Evans, C.H.12
-
20
-
-
0032739075
-
Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts
-
10.1172/JCI6093, 408475, 10411542
-
Takayanagi H, Juji T, Miyazaki T, Iizuka H, Takahashi T, Isshiki M, Okada M, Tanaka Y, Koshihara Y, Oda H, Kurokawa T, Nakamura K, Tanaka S. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. J Clin Invest 1999, 104:137-146. 10.1172/JCI6093, 408475, 10411542.
-
(1999)
J Clin Invest
, vol.104
, pp. 137-146
-
-
Takayanagi, H.1
Juji, T.2
Miyazaki, T.3
Iizuka, H.4
Takahashi, T.5
Isshiki, M.6
Okada, M.7
Tanaka, Y.8
Koshihara, Y.9
Oda, H.10
Kurokawa, T.11
Nakamura, K.12
Tanaka, S.13
-
21
-
-
0030853159
-
Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer
-
10.1172/JCI119726, 508384, 9329958
-
Zhang H, Yang Y, Horton JL, Samoilova EB, Judge TA, Turka LA, Wilson JM, Chen Y. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J Clin Invest 1997, 100:1951-1957. 10.1172/JCI119726, 508384, 9329958.
-
(1997)
J Clin Invest
, vol.100
, pp. 1951-1957
-
-
Zhang, H.1
Yang, Y.2
Horton, J.L.3
Samoilova, E.B.4
Judge, T.A.5
Turka, L.A.6
Wilson, J.M.7
Chen, Y.8
-
22
-
-
0030847418
-
Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy
-
10.1038/sj.gt.3300486, 9349435
-
Ghivizzani SC, Lechman ER, Tio C, Mule KM, Chada S, McCormack JE, Evans CH, Robbins PD. Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy. Gene Ther 1997, 4:977-982. 10.1038/sj.gt.3300486, 9349435.
-
(1997)
Gene Ther
, vol.4
, pp. 977-982
-
-
Ghivizzani, S.C.1
Lechman, E.R.2
Tio, C.3
Mule, K.M.4
Chada, S.5
McCormack, J.E.6
Evans, C.H.7
Robbins, P.D.8
-
23
-
-
77949424429
-
Progress and prospects: immune responses to viral vectors
-
10.1038/gt.2009.148, 19907498
-
Nayak S, Herzog RW. Progress and prospects: immune responses to viral vectors. Gene Ther 2010, 17:295-304. 10.1038/gt.2009.148, 19907498.
-
(2010)
Gene Ther
, vol.17
, pp. 295-304
-
-
Nayak, S.1
Herzog, R.W.2
-
24
-
-
0037162490
-
Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis
-
10.1073/pnas.132254199, 126607, 12089323
-
Backlund J, Carlsen S, Hoger T, Holm B, Fugger L, Kihlberg J, Burkhardt H, Holmdahl R. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA 2002, 99:9960-9965. 10.1073/pnas.132254199, 126607, 12089323.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 9960-9965
-
-
Backlund, J.1
Carlsen, S.2
Hoger, T.3
Holm, B.4
Fugger, L.5
Kihlberg, J.6
Burkhardt, H.7
Holmdahl, R.8
-
25
-
-
0034786078
-
Role of glycopeptide-specific T cells in collagen-induced arthritis: an example how post-translational modification of proteins may be involved in autoimmune disease
-
10.3109/07853890109002094, 11680793
-
Corthay A, Backlund J, Holmdahl R. Role of glycopeptide-specific T cells in collagen-induced arthritis: an example how post-translational modification of proteins may be involved in autoimmune disease. Ann Med 2001, 33:456-465. 10.3109/07853890109002094, 11680793.
-
(2001)
Ann Med
, vol.33
, pp. 456-465
-
-
Corthay, A.1
Backlund, J.2
Holmdahl, R.3
-
26
-
-
0028227873
-
T cell recognition of carbohydrates on type II collagen
-
10.1084/jem.180.2.745, 2191590, 8046350
-
Michaelsson E, Malmstrom V, Reis S, Engstrom A, Burkhardt H, Holmdahl R. T cell recognition of carbohydrates on type II collagen. J Exp Med 1994, 180:745-749. 10.1084/jem.180.2.745, 2191590, 8046350.
-
(1994)
J Exp Med
, vol.180
, pp. 745-749
-
-
Michaelsson, E.1
Malmstrom, V.2
Reis, S.3
Engstrom, A.4
Burkhardt, H.5
Holmdahl, R.6
-
27
-
-
31144450506
-
Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules
-
Dzhambazov B, Nandakumar KS, Kihlberg J, Fugger L, Holmdahl R, Vestberg M. Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules. J Immunol 2006, 176:1525-1533.
-
(2006)
J Immunol
, vol.176
, pp. 1525-1533
-
-
Dzhambazov, B.1
Nandakumar, K.S.2
Kihlberg, J.3
Fugger, L.4
Holmdahl, R.5
Vestberg, M.6
-
28
-
-
1842683024
-
An analog peptide that suppresses collagen-induced arthritis
-
10.1097/00000441-200404000-00007, 15084917
-
Myers LK, Sakurai Y, Rosloniec EF, Stuart JM, Kang AH. An analog peptide that suppresses collagen-induced arthritis. Am J Med Sci 2004, 327:212-216. 10.1097/00000441-200404000-00007, 15084917.
-
(2004)
Am J Med Sci
, vol.327
, pp. 212-216
-
-
Myers, L.K.1
Sakurai, Y.2
Rosloniec, E.F.3
Stuart, J.M.4
Kang, A.H.5
|